EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study

Udit Nindra iD, Joanne Tang iD, Jun Hee Hong iD, Joseph Descallar iD, Martin Hong iD, Andrew Killen, Priyadarshini Dubey, Jeneen Attaullah, Grace Scott, Adam Cooper, Kate Wilkinson, Abhijit Pal iD und 6 weitere

JCO Oncology Practice · 2026

DOI: 10.1200/op-25-00412 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JCO Oncology Practice, 2026. Verfasst von Udit Nindra und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Wollongong Hospital, Wollongong, Australia. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Early-phase clinical trials (EP-CTs) provide access to novel therapeutics for patients with limited standard treatment options. Beyond drug-related risks, participants may experience hidden toxicities, including time, financial, and social burdens that often go unmeasured. METHODS The Patient Experience in Early-Phase Cancer Clinical Trials (PEARLER) study aimed to assess time, financial, and social toxicity (ST) in a prospective, multicenter cohort. Participants completed a time toxicity (TT) survey and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 on day 1 of cycles 1-6. Financial toxicity (FT) was assessed using the EORTC scoring manual; ST was evaluated using the social and role functioning domains. Multilevel models examined trends over time. RESULTS A total of 122 participants (median age 62 years, range, 25-83) were enrolled. Median objective TT was 26%. Only 16% (20/122) reported subjective TT, most commonly during cycles 1-2 (85%). FT was reported by 44% (54/122), but did not significantly change over time ( P = .136). Although 71% (87/122) reported some reduction in social function, social functioning scores remained stable throughout trial participation. Role functioning declined in participants age 60 years and younger but was maintained in those older than 60 years. CONCLUSION To our knowledge, PEARLER is the first prospective study to assess TT, FT, and ST in Australian EP-CTs. Although objective time burden was measurable, few patients perceived it as problematic beyond early cycles. FT and ST were commonly reported but remained stable over time. These findings suggest that EP-CT participation may not negatively affect patient-reported quality-of-life domains and provide reassurance for both clinicians and patients considering enrollment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansMiddle AgedFemaleMaleProspective StudiesAgedAdultAustraliaQuality of LifeAged, 80 and overPatient Reported Outcome MeasuresSurveys and QuestionnairesTime Factors

Autor:innen und Institutionen

  • Department of Medical Oncology, Wollongong Hospital, Wollongong, Australia.
  • Department of Medicine, University of Wollongong, Wollongong, Australia.
  • Department of Medical Oncology, Liverpool Hospital, Liverpool, Australia.
  • Department of Medicine, Western Sydney University, Campbelltown, Australia.
  • Ingham Institute for Applied Medical Research, Liverpool, Australia.
  • South Western Sydney Clinical Campuses, School of Clinical Medicine, UNSW Sydney, Kensington, Australia.

ORCID-Profile: Udit Nindra, Joanne Tang, Jun Hee Hong, Joseph Descallar, Martin Hong, Abhijit Pal, Christina Teng, Joe Wei

Zitieren

APA

Nindra, U., Tang, J., Hong, J. H., Descallar, J., Hong, M., Killen, A., Dubey, P., Attaullah, J., Scott, G., Cooper, A., Wilkinson, K., Pal, A., Teng, C., Roohullah, A., Wei, J., Ng, W., Lemech, C., & Chua, W. (2026). Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study. JCO Oncology Practice. https://doi.org/10.1200/op-25-00412

Vancouver

Nindra U, Tang J, Hong JH, Descallar J, Hong M, Killen A, et al. Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study. JCO Oncology Practice. 2026. doi:10.1200/op-25-00412

BibTeX
@article{Nindra2026,
  author = {Nindra, Udit and Tang, Joanne and Hong, Jun Hee and Descallar, Joseph and Hong, Martin and Killen, Andrew and Dubey, Priyadarshini and Attaullah, Jeneen and Scott, Grace and Cooper, Adam and Wilkinson, Kate and Pal, Abhijit and Teng, Christina and Roohullah, Aflah and Wei, Joe and Ng, Weng and Lemech, Charlotte and Chua, Wei},
  title = {Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study},
  journal = {JCO Oncology Practice},
  year = {2026},
  doi = {10.1200/op-25-00412}
}
Kostenlos starten →